Navigation Links
Local Head-Injury Patients Sought for Study Investigating Potential Treatment for Daytime Sleepiness
Date:1/12/2010

KING OF PRUSSIA, Pa., Jan. 12 /PRNewswire/ -- Local patients are being sought for a national clinical research study currently investigating a study medication for people who have had a head injury, concussion or bump on the head and feel sleepy or tired during the day.  According to the Centers for Disease Control and Prevention, head injury is one of the most common neurologic disorders, affecting around 1.5 million Americans every year. Many people with a past head injury feel sleepy during the day, yet few people know that their sleepiness might be connected to this injury.  People experiencing daytime sleepiness who have had one head injury within the last 10 years are encouraged to contact the clinical research screening center at 1-877-674-6317 or go to www.HeadInjuryResearchStudy.com for more information and where they can take the pre-screening questionnaire to see if they are eligible for the study.

"Currently, there are no treatments for patients who suffer from sleepiness during the day as a result of head injury," according to study investigator Dr. Milton Erman, MD at Avastra Clinical Trials. "Consequently, there is a great need for new medicines to treat this life-changing problem."

The clinical study is specifically designed for adults aged 18 to 65 who have had a head injury, concussion, or bump on the head within the last 10 years and feel sleepy or tired during the day. It will examine different dosage strengths of the study medicine and how patients respond to them. Eligible participants may receive medical care related to the study at no cost and be reimbursed for time and travel as a result of taking part in the trial.

A recent online survey of more than 100 people who have had a previous head injury found that feeling sleepy during the day negatively affects their work and family life. The survey was conducted by MediciGlobal, a patient communications firm working with Cephalon, Inc., the biopharmaceutical company sponsoring the study.

"Seventy percent of head injury sufferers surveyed said that their daytime sleepiness affects their ability to effectively interact with their family and co-workers, and seriously impacts long-term relationships," said Dr. Erman.  "This study is important because daytime sleepiness can negatively impact the daily lives of so many patients suffering from head injuries."

About the Study Sponsor

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology.

SOURCE MediciGlobal

RELATED LINKS
http://www.HeadInjuryResearchStudy.com

'/>"/>

SOURCE MediciGlobal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer
2. Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption
3. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
4. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
5. Local Research Foundation Achieves Milestone in Fight Against Cancer
6. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
7. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
8. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
9. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
10. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
11. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
Breaking Medicine News(10 mins):